Gregory Friedman

Gregory Friedman is a Senior Professor at The University of Texas MD Anderson Cancer Center. His research focuses on neuro-oncology, specifically pediatric brain tumors, gliomas, and the development of novel cancer therapeutics. His recent work includes pioneering clinical and translational advances in oncolytic virotherapy for pediatric CNS tumors, identifying survival benefits of gabapentinoids in glioblastoma, and investigating chemo-immunotherapy-induced T-cell responses in pediatric brain tumors. He has also contributed to treatment strategies for leptomeningeal disease and pediatric solid tumors. His research integrates radiation oncology, pharmacology, and immunotherapy to improve outcomes for patients with aggressive brain and pediatric cancers.